Clinical Trial Search

Primary: Number of Participants With Procedure Success — 121 Participants

Primary: Procedure Success — 119 Participants

Primary: Number of Participants With Stent-related: Major Adverse Cardiac Events (MACE) (Per ITT Set) — 39 Participants

Primary: Primary Safety Endpoint — 2 Percent of participants

Primary: Major Adverse Events — 4 participants

Primary: Composite Rate of Major Adverse Events — 3.3 percentage of participants

Primary: Number of Patients That Had a First Occurrence of the Primary End Point (Composite of Death From Any Cause, Nonfatal MI, or Class IV HF) — 230; 219 participants

Primary: MLD SB Diameter — 08.; 1.0; 2.3; 2.2 mm

Primary: Percentage of Participants With Major Adverse Cardiac Events(MACE) — 1.72; 6.86 percentage of participants

Primary: Technical Success — 77 percentage of CTOs

Primary: Primary Effectiveness Endpoint: Late Lumen Loss (LLL) at 9 Months — 0.892; 1.312 mm

Primary: Number of Major Adverse Cardiac Events (MACE) — 9; 6; 2; 119 Participants

Primary: Coronary Flow Reserve (CFR) — 2.23 Ratio

Primary: The Sensitivity and Specificity of ECG for Acute Coronary Occlusion. — 767; 282; 16 Participants

Primary: Minimum Stent Area After Percutaneous Coronary Intervention — 6.7; 6.9 mm^2

Primary: Procedural Success — 91.4 percentage of participants

Primary: Composite of: — 14 Participants

Primary: Hospital Mortality Rate — 6; 2 Participants

Primary: Number of Participants With Side Branch Compromise — 7; 9 Participants

Primary: Comparison of CCTA Alone to FFR-CT After CCTA — 90.97; 92.73; 22.86; 69.71 percent — p=1.00

Primary: Number of Flow-limiting Coronary Artery Stenosis on CT — 8 Coronary arteries

Primary: Primary Safety Endpoint: 30-Day Freedom From Major Adverse Cardiac Events (MACE) — 89.6 Percent probability of Freedom from MACE

Primary: Rate of Complete ST-segment Elevation Resolution at 60 Minutes After the End of the Procedure — 38; 58 Participants

Primary: Myocardial Perfusion Reserve — 2.76; 2.47; 2.82; 2.52 Ratio

Primary: Rates of Major Cardiac Events (AMI or Cardiac Death) Within 30 Days — 0; 0; 0; 10 Participants

Primary: Number of Participants With Combination of All Cause Death, Non-fatal Myocardial Infarction (MI), and Hospitalization for Unstable Angina — 34; 28 Participants

Primary: MACCE — 80; 51 Participants — p=0.35

Primary: MACE at 30 Days — 2.3; 3.1; 15 Percent probability of MACE

Primary: Primary Composite Outcome: Death From Cardiovascular Causes, Myocardial Infarction, or Hospitalization for Unstable Angina, Heart Failure, or Resuscitated Cardiac Arrest…

Primary: All-cause Death or Subsequent Non-fatal Type 1 or Type 4b MI at One Year Measured as Time to First Such Event. — 51; 53 Participants